2017
DOI: 10.1016/j.clineuro.2017.04.022
|View full text |Cite
|
Sign up to set email alerts
|

Effects of preadmission beta-blockers on neurogenic stunned myocardium after aneurysmal subarachnoid hemorrhage: A meta- analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 18 publications
0
11
0
Order By: Relevance
“…Intracranial aneurysm rupture is the main reason for spontaneous subarachnoid hemorrhage (SAH) [ 1 ]. Due to the high morbidity and fatality rate, as well as the possibility of rebleeding, intracranial aneurysm seriously threatens human life.…”
Section: Introductionmentioning
confidence: 99%
“…Intracranial aneurysm rupture is the main reason for spontaneous subarachnoid hemorrhage (SAH) [ 1 ]. Due to the high morbidity and fatality rate, as well as the possibility of rebleeding, intracranial aneurysm seriously threatens human life.…”
Section: Introductionmentioning
confidence: 99%
“…In this regard, there is a wealth of clinical data demonstrating that β-blockers protect the heart against catecholamine-derived injury (Lymperopoulos et al, 2013). Yet, β-blockade in SAH has yielded mixed results: while a few studies purport a beneficial, cardioprotective effect (Neil-Dwyer et al, 1985;Liang et al, 2013), most other retrospective studies find no concrete evidence that taking β-blockers prior to SAH protects against neurocardiac injury (Malik et al, 2015;Luo et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Diagnosis and treatment of CAV has been well described in literature, but data in SAH remains scarce. Some research has been attempted in this area, in which prophylactic beta-blockers were hypothesized to reduce catecholaminergic surges in order to reduce the incidence and complications that arise from NSM, but a meta-analysis by Luo et al[ 20 ] showed no statistical benefit to this therapy. Clinical evidence is widespread for CAV and treatment modalities using nitrates and calcium-channel blockers; however, in the subset of patients complicated by SAH, there is limited data regarding acute cardioprotective strategies[ 3 ].…”
Section: Discussionmentioning
confidence: 99%